TY - JOUR
T1 - Comprehensive epigenome characterization reveals diverse transcriptional regulation across human vascular endothelial cells
AU - Nakato, Ryuichiro
AU - Wada, Youichiro
AU - Nakaki, Ryo
AU - Nagae, Genta
AU - Katou, Yuki
AU - Tsutsumi, Shuichi
AU - Nakajima, Natsu
AU - Fukuhara, Hiroshi
AU - Iguchi, Atsushi
AU - Kohro, Takahide
AU - Kanki, Yasuharu
AU - Saito, Yutaka
AU - Kobayashi, Mika
AU - Izumi-Taguchi, Akashi
AU - Osato, Naoki
AU - Tatsuno, Kenji
AU - Kamio, Asuka
AU - Hayashi-Takanaka, Yoko
AU - Wada, Hiromi
AU - Ohta, Shinzo
AU - Aikawa, Masanori
AU - Nakajima, Hiroyuki
AU - Nakamura, Masaki
AU - McGee, Rebecca C.
AU - Heppner, Kyle W.
AU - Kawakatsu, Tatsuo
AU - Genno, Michiru
AU - Yanase, Hiroshi
AU - Kume, Haruki
AU - Senbonmatsu, Takaaki
AU - Homma, Yukio
AU - Nishimura, Shigeyuki
AU - Mitsuyama, Toutai
AU - Aburatani, Hiroyuki
AU - Kimura, Hiroshi
AU - Shirahige, Katsuhiko
N1 - Publisher Copyright:
© 2019 The Author(s).
PY - 2019/12/19
Y1 - 2019/12/19
N2 - Background: Endothelial cells (ECs) make up the innermost layer throughout the entire vasculature. Their phenotypes and physiological functions are initially regulated by developmental signals and extracellular stimuli. The underlying molecular mechanisms responsible for the diverse phenotypes of ECs from different organs are not well understood. Results: To characterize the transcriptomic and epigenomic landscape in the vascular system, we cataloged gene expression and active histone marks in nine types of human ECs (generating 148 genome-wide datasets) and carried out a comprehensive analysis with chromatin interaction data. We developed a robust procedure for comparative epigenome analysis that circumvents variations at the level of the individual and technical noise derived from sample preparation under various conditions. Through this approach, we identified 3765 EC-specific enhancers, some of which were associated with disease-associated genetic variations. We also identified various candidate marker genes for each EC type. We found that the nine EC types can be divided into two subgroups, corresponding to those with upper-body origins and lower-body origins, based on their epigenomic landscape. Epigenomic variations were highly correlated with gene expression patterns, but also provided unique information. Most of the deferentially expressed genes and enhancers were cooperatively enriched in more than one EC type, suggesting that the distinct combinations of multiple genes play key roles in the diverse phenotypes across EC types. Notably, many homeobox genes were differentially expressed across EC types, and their expression was correlated with the relative position of each organ in the body. This reflects the developmental origins of ECs and their roles in angiogenesis, vasculogenesis and wound healing. Conclusions: This comprehensive analysis of epigenome characterization of EC types reveals diverse transcriptional regulation across human vascular systems. These datasets provide a valuable resource for understanding the vascular system and associated diseases.
AB - Background: Endothelial cells (ECs) make up the innermost layer throughout the entire vasculature. Their phenotypes and physiological functions are initially regulated by developmental signals and extracellular stimuli. The underlying molecular mechanisms responsible for the diverse phenotypes of ECs from different organs are not well understood. Results: To characterize the transcriptomic and epigenomic landscape in the vascular system, we cataloged gene expression and active histone marks in nine types of human ECs (generating 148 genome-wide datasets) and carried out a comprehensive analysis with chromatin interaction data. We developed a robust procedure for comparative epigenome analysis that circumvents variations at the level of the individual and technical noise derived from sample preparation under various conditions. Through this approach, we identified 3765 EC-specific enhancers, some of which were associated with disease-associated genetic variations. We also identified various candidate marker genes for each EC type. We found that the nine EC types can be divided into two subgroups, corresponding to those with upper-body origins and lower-body origins, based on their epigenomic landscape. Epigenomic variations were highly correlated with gene expression patterns, but also provided unique information. Most of the deferentially expressed genes and enhancers were cooperatively enriched in more than one EC type, suggesting that the distinct combinations of multiple genes play key roles in the diverse phenotypes across EC types. Notably, many homeobox genes were differentially expressed across EC types, and their expression was correlated with the relative position of each organ in the body. This reflects the developmental origins of ECs and their roles in angiogenesis, vasculogenesis and wound healing. Conclusions: This comprehensive analysis of epigenome characterization of EC types reveals diverse transcriptional regulation across human vascular systems. These datasets provide a valuable resource for understanding the vascular system and associated diseases.
KW - ChIP-seq
KW - Endothelial cells
KW - Epigenome database
KW - Histone modifications
KW - Large-scale analysis
UR - http://www.scopus.com/inward/record.url?scp=85077087617&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85077087617&partnerID=8YFLogxK
U2 - 10.1186/s13072-019-0319-0
DO - 10.1186/s13072-019-0319-0
M3 - Article
C2 - 31856914
AN - SCOPUS:85077087617
SN - 1756-8935
VL - 12
JO - Epigenetics and Chromatin
JF - Epigenetics and Chromatin
IS - 1
M1 - 77
ER -